In our study, however, we used human glioblastoma astrocytes with identical genetic material to specifically assess potential differences in the ability of CSF lipoproteins to promote cellular cholesterol efflux, thereby minimizing any confounding effects from cellular APOE variations. This evidence concerns the gene APOE and glioblastoma.